The meeting of the Advisory Committee on Complementary Medicines (ACCM).
The committee's advice and comment was sought on:
- The sufficiency and reliability of the evidence to support the registration of a probiotic complementary medicine, as well as whether the product is suitable to be a self-selected medicine without healthcare professional involvement.
- What constitutes adequate control of the composition, strength, stability and performance characteristics of a multi-strain probiotic product.
Members
Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 27 November 2019